No More “Wait and See”: Two Clinical Trials Target the Origins of Recurrent Ovarian Cancer
Break Through Cancer scientists are evaluating a “second-look” technique to measure and destroy persistent cancer cells resistant to frontline chemotherapy. CAMBRIDGE, MA, UNITED STATES, September 26, 2024 /EINPresswire.com/ -- After initial therapy to …